Esther
Molina Perez
![Foto de Esther](/img/nophoto.png)
![Foto de Imperial College Healthcare NHS Trust](/img/noimage_org.png)
Imperial College Healthcare NHS Trust
Londres, Reino UnidoPublications in collaboration with researchers from Imperial College Healthcare NHS Trust (1)
2016
-
Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)
Antiviral Therapy, Vol. 21, Núm. 3, pp. 195-205